Mike Pellini, MD (@michaelpellini) 's Twitter Profile
Mike Pellini, MD

@michaelpellini

Managing Partner, Section 32. Former CEO/Chairman, Foundation Medicine. Former Pres/COO, Clarient (GEHC). #PersonalizedMedicine is the only way.

ID: 398129689

linkhttp://www.section32.com calendar_today25-10-2011 16:31:20

2,2K Tweet

3,3K Followers

502 Following

Peter Kolchinsky (@peterkolchinsky) 's Twitter Profile Photo

My friends & peers outraged that a European country would launch an unprovoked invasion of its neighbor, please read this letter urging maximal economic disengagement from Russian industry/elites. I hope you’ll sign on- many business leaders already have. medium.com/@BusinessLeade…

Mike Pellini, MD (@michaelpellini) 's Twitter Profile Photo

Idiots. Can't you see what is going on in this world right now, yet this path is your choice? Open your eyes. 5. Truck convoy on D.C. doorstep axios.com/newsletters/ax… #axiosam

SandboxAQ (@sandboxaq) 's Twitter Profile Photo

As the world enters the 3rd quantum era, #SandboxAQ is already delivering practical #AI and #quantum hardware, applications and services that address real-world challenges -- that don't require #quantumcomputers sandboxaq.com

As the world enters the 3rd quantum era, #SandboxAQ is already delivering practical #AI and #quantum hardware, applications and services that address real-world challenges -- that don't require #quantumcomputers sandboxaq.com
S32 (@s32_vc) 's Twitter Profile Photo

Today Satellite Bio emerged from stealth mode, announcing their Series A financing. Through pioneering an entirely new type of #regenerativemedicine, the team is at the forefront of targeting the world’s most elusive diseases. businesswire.com/news/home/2022…

Mike Pellini, MD (@michaelpellini) 's Twitter Profile Photo

Interpace Biosciences, Miroculus, Twist Bioscience Partner to Automate NGS Library Prep in Cancer Dx genomeweb.com/sequencing/int…

Miroculus (@miroculus) 's Twitter Profile Photo

We are proud to be partnering with Element Biosciences to automate library preparation on the Miro Canvas for the AVITI System. Visit us at #AGBT22 to learn more. businesswire.com/news/home/2022…

We are proud to be partnering with <a href="/ElemBio/">Element Biosciences</a> to automate library preparation on the Miro Canvas for the AVITI System. Visit us at #AGBT22 to learn more.

businesswire.com/news/home/2022…
Mike Pellini, MD (@michaelpellini) 's Twitter Profile Photo

Hey @RonDeSantisFL, please remember these are real human beings you are using in this fashion. You might have forgotten that basic principle. cnn.com/2022/09/14/pol…

Mike Pellini, MD (@michaelpellini) 's Twitter Profile Photo

Not sure how I missed this article last week. Anyone even a TINY BIT surprised by these actions? ‘The Cash Monster Was Insatiable’: How Insurers Exploited Medicare for Billions nytimes.com/2022/10/08/ups…

Mike Pellini, MD (@michaelpellini) 's Twitter Profile Photo

Congrats to ⁦Medcrypt⁩ team. The momentum builds. As a longtime life sciences COO-CEO, I know how much we need this type of security for lab and medical devices. techcrunch-com.cdn.ampproject.org/c/s/techcrunch…

Mike Pellini, MD (@michaelpellini) 's Twitter Profile Photo

Our country has become so disgustingly tone deaf to gun violence that it is almost impossible to believe. What will it take to end the insanity? via The New York TimesNRA⁩ ☠️☠️☠️ nytimes.com/2022/11/23/us/…

Mike Pellini, MD (@michaelpellini) 's Twitter Profile Photo

I guess Twitter is an open platform until it’s not. The account seemed factual? Maybe their ethics committee called it out. Oh wait…… bloomberg.com/news/articles/…

Mike Pellini, MD (@michaelpellini) 's Twitter Profile Photo

Brilliant. Awesome. A great long term perspective without punishing citizens who grew up with cigarettes and can't #justquit. #NewZealand leading the way again. nytimes.com/2022/12/14/wor…

Karen Knudsen, MBA PhD (@drkarenknudsen) 's Twitter Profile Photo

To end cancer as we know it, precision oncology must be part of the solution. Toward that goal, we are thrilled that personalized medicine/life sciences/healthcare pioneer, and bona fide cancer fighter Mike Pellini, MD has joined the American Cancer Society Board. bit.ly/3G9YC8d

To end cancer as we know it, precision oncology must be part of the solution. Toward that goal, we are thrilled that personalized medicine/life sciences/healthcare pioneer, and bona fide cancer fighter <a href="/MichaelPellini/">Mike Pellini, MD</a> has joined the <a href="/AmericanCancer/">American Cancer Society</a> Board.  bit.ly/3G9YC8d
Mike Pellini, MD (@michaelpellini) 's Twitter Profile Photo

Great progress but plenty of opportunities to do better, especially wrt #prostatecancer Thanks American Cancer Society for facts, figures, and analysis cancerletter.com/guest-editoria…

Mike Pellini, MD (@michaelpellini) 's Twitter Profile Photo

Hey Uber, your service in #PaloAlto has gone to absolute hell. I never thought I’d be longing for the days of a “good” old fashion #taxi.

Mike Pellini, MD (@michaelpellini) 's Twitter Profile Photo

Non-Tesla charging network is nowhere near ready for primetime.Esp Electrify America #EV efforts would be 20 yrs delayed w/o Tesla and Elon Musk. Pls open your charging network (though it’s a heck of a comp adv!) 🛣️ EV road trip brings "range anxiety" axios.com/newsletters/ax… #axiosam

Karen Knudsen, MBA PhD (@drkarenknudsen) 's Twitter Profile Photo

MCEDs, once FDA approved and shown to provide clinical benefit, hold significant potential for early detection of cancer. Today’s step lays the path toward ensuring access to promising new technologies that can help end cancer as we know it, for everyone. bit.ly/MCED1